Company Filing History:
Years Active: 2021-2025
Title: Fabiana Perna: Innovator in Cancer Research
Introduction
Fabiana Perna is a prominent inventor based in New York, NY, specializing in cancer research. She has made significant contributions to the field, particularly in the development of innovative treatments for myeloid disorders. With a total of 3 patents to her name, her work is paving the way for advancements in cancer therapy.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Cancer antigen targets and uses thereof." This patent provides methods and compositions for treating myeloid disorders, such as acute myeloid leukemia (AML). It focuses on immunoresponsive cells that bear antigen recognizing receptors, specifically chimeric antigen receptors (CARs), which target AML-specific antigens. This innovative approach holds promise for improving treatment outcomes for patients suffering from these challenging conditions.
Career Highlights
Fabiana Perna is affiliated with the Memorial Sloan Kettering Cancer Center, where she conducts her research and develops her inventions. Her work at this prestigious institution has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.
Collaborations
One of her notable collaborators is Michel Sadelain, a respected figure in cancer research. Together, they work on innovative solutions that aim to enhance the effectiveness of cancer therapies.
Conclusion
Fabiana Perna's contributions to cancer research and her innovative patents are making a significant impact in the fight against myeloid disorders. Her dedication to advancing medical science continues to inspire and drive progress in the field of oncology.